NWSA
75
2
SNA
52
-3
TEL
68
-6
JWN
46
-4
HST
33
-5
APA
23
-2
GRMN
56
-2
AVY
72
-3
MSI
52
-2
KHC
22
2
CA
44
4
NTAP
66
-8
BF.B
50
3
FSLR
67
-8
XYL
41
-6
PEG
41
-2
ECL
64
-16
ABBV
66
4
IR
69
-5
CAG
33
2
NWSA
75
2
SNA
52
-3
TEL
68
-6
JWN
46
-4
HST
33
-5
APA
23
-2
GRMN
56
-2
AVY
72
-3
MSI
52
-2
KHC
22
2
CA
44
4
NTAP
66
-8
BF.B
50
3
FSLR
67
-8
XYL
41
-6
PEG
41
-2
ECL
64
-16
ABBV
66
4
IR
69
-5
CAG
33
2
Financhill
Back

BioNTech SE Stock Predictions

Sell
32

BNTX
BioNTech SE

Last Price:
92.10
Seasonality Move:
23.17%

7 Day Trial

ALL ACCESS PASS

$ 7

BioNTech SE Stock Forecast

  • Over the next 52 weeks, BioNTech SE has on average historically risen by 82.3% based on the past 4 years of stock performance.
  • BioNTech SE has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is BioNTech SE Stock Undervalued?
    The current BioNTech SE [BNTX] share price is $92.08. The Score for BNTX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • BNTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will BioNTech SE Stock Go Up Next Year?

  • Over the next 52 weeks, BioNTech SE has on average historically risen by 82.3% based on the past 4 years of stock performance.

BioNTech SE Stock Rating

Sell
32
BioNTech SE (BNTX) is a Sell

Is BioNTech SE overpriced?

  • BioNTech SE has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

BioNTech SE Stock Price History

Is BNTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Germany
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biontech.de

52-Week Data

52-Week High:
125.83
52-Week Low:
85.21

Prediction Charts

Market Cap:
22.19B
Price in USD:
92.08
Volume:
764.55K
Beta:
0.27

Technical Analysis

SMA50:
92.68
SMA100:
92.80
SMA200:
98.39
52-Wk Change:
-17.01%

Stock Predictions

  • Is BioNTech SE stock public?
    Yes, BioNTech SE is a publicly traded company.
  • What is the BioNTech SE stock quote today?
    The BioNTech SE stock price is 92.08 USD today.
  • How to buy BioNTech SE stock online?
    You can buy BioNTech SE shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-28 97.72 94.09 97.72 92.57
May-29 93.02 93.24 93.54 91.57
May-30 94.00 98.75 103.41 92.39
May-31 99.50 100.60 103.57 98.62
Jun-3 100.00 102.90 103.75 99.67
Jun-4 103.32 99.48 103.32 99.11
Jun-5 99.70 102.50 102.70 98.55
Jun-6 102.56 101.81 104.33 101.68
Jun-7 101.00 100.34 101.96 100.29
Jun-10 99.66 97.98 99.96 97.40
Jun-11 97.64 98.80 99.36 97.11
Jun-12 101.85 97.91 101.87 97.51
Jun-13 97.79 95.99 98.28 95.24
Jun-14 94.26 92.08 95.24 92.02

BioNTech SE Earnings

BioNTech SE Earnings Report: Per Share BioNTech SE Earnings Q1 Q2 Q3 and Q4 last year and next year.

BioNTech SE Forecast Revenue Growth

BioNTech SE Stock Analysis: Historical quarterly revenues per share for BioNTech SE and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.82 per share, a decrease next quarter of $0.67 per share, a decrease this year of $6.67 per share, and a decrease next year of $0.60 per share.

* BioNTech SE stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.